Your browser doesn't support javascript.
loading
Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.
Leroy, Vaianu; Henrot, Pauline; Barnetche, Thomas; Cario, Muriel; Darrigade, Anne-Sophie; Manicki, Pauline; Doutre, Marie-Sylvie; Lazaro, Estibaliz; Constans, Joel; Barcat, Damien; Vernhes, Jean-Philippe; Richez, Christophe; Taieb, Alain; Truchetet, Marie-Elise; Seneschal, Julien.
Afiliação
  • Leroy V; Department of Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France.
  • Henrot P; Department of Rheumatology, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France; Inserm U1035, Biothérapie des Maladies Génétiques et Cancers, University of Bordeaux, Bordeaux, France.
  • Barnetche T; Department of Rheumatology, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France.
  • Cario M; Inserm U1035, Biothérapie des Maladies Génétiques et Cancers, University of Bordeaux, Bordeaux, France.
  • Darrigade AS; Department of Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France.
  • Manicki P; Department of Rheumatology, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France.
  • Doutre MS; Department of Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France.
  • Lazaro E; Department of Internal Medicine, Hôpital Haut-Levêque, CHU de Bordeaux, Bordeaux, France.
  • Constans J; Department of Vascular Medicine, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France.
  • Barcat D; Department of Internal Medicine, Hôpital Robert Boulin, Libourne, France.
  • Vernhes JP; Department of Rheumatology, Hôpital Robert Boulin, Libourne.
  • Richez C; Department of Rheumatology, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France.
  • Taieb A; Department of Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France; Inserm U1035, Biothérapie des Maladies Génétiques et Cancers, University of Bordeaux, Bordeaux, France.
  • Truchetet ME; Department of Rheumatology, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France; Immunoconcept, CNRS UMR 5164, Bordeaux University, Bordeaux, France.
  • Seneschal J; Department of Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France; Inserm U1035, Biothérapie des Maladies Génétiques et Cancers, University of Bordeaux, Bordeaux, France. Electronic address: julien.seneschal@chu-bordeaux.fr.
J Am Acad Dermatol ; 80(2): 478-484, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30092330
ABSTRACT

BACKGROUND:

Skin pigmentation disorders in systemic sclerosis (SSc) have been sparsely described in the literature. Nevertheless, they could be a diagnostic and/or severity marker.

OBJECTIVES:

To assess the association between pigmentation disorders and systemic involvement in patients with SSc.

METHODS:

A total of 5 patterns of skin pigmentation disorders were defined diffuse hyperpigmentation; hyperpigmentation of sun-exposed areas; hypopigmentation of the head, neck, and/or upper part of the chest; acral hypopigmentation; and diffuse hypopigmentation.

RESULTS:

A total of 239 patients were included; 88 patients (36.8%) had skin pigmentation disorders as follows diffuse hyperpigmentation and hyperpigmentation of sun-exposed areas in 38.6% (n = 34) and 27.3% (n = 24) of patients, respectively; hypopigmentation of the face, neck, and/or chest in 10.2% of patients (n = 9); diffuse hypopigmentation in 12.5% (n = 11); and acral hypopigmentation in 17% (n = 15). Diffuse hyperpigmentation was associated with diffuse SSc (P = .001), increased modified Rodnan skin score (P = .001), and shorter duration of Raynaud phenomenon (P = .002) in univariate analysis but not in multivariate analysis. Moreover, diffuse hyperpigmentation was associated with digital ulcers (P = .005), as confirmed by multivariate analysis (odds ratio, 2.96; 95% confidence interval, 1.28-6.89).

LIMITATIONS:

This was a single-center retrospective study of a cohort of patients with SSc.

CONCLUSION:

Screening for skin pigmentation disorders could be useful in the management of patients with SSc to identify those with a high risk of development of digital ulcers, which is a symptom of vascular involvement in SSc.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Úlcera Cutânea / Hiperpigmentação / Dedos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Úlcera Cutânea / Hiperpigmentação / Dedos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França